跳至主要内容
临床试验/NCT02741297
NCT02741297已完成不适用

A Multi-Center Controlled Study to Characterize the Real-world Outcomes of High Rate Spinal Cord Stimulation Therapy Using Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System

Boston Scientific Corporation5 个研究点 分布在 4 个国家目标入组 73 人开始时间: 2016年4月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
73
试验地点
5
主要终点
Percentage of Low Back Pain Responders

研究概览

简要总结

The primary objective of this study is to characterize the real-world outcomes of spinal cord stimulation (SCS) therapy as an aid in the management of chronic intractable pain of the trunk, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain using the Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System with MultiWave Technology.

详细描述

The purpose of this study is to characterize the real-world outcomes of spinal cord stimulation (SCS) therapy as an aid in the management of chronic intractable pain of the trunk, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain using the Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System with MultiWave Technology.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Complaint of persistent or recurrent low back pain for at least 180 days prior to Screening
  • Willing and able to comply with all protocol-required procedures and assessments/evaluations
  • Subject signed a valid, ethics committee (EC)-approved informed consent form (ICF) provided in local language

排除标准

  • High surgical risk
  • Previous spinal cord stimulation trial or is already implanted with an active implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator)
  • A female who is pregnant, is breastfeeding, or is of childbearing potential and planning to get pregnant during the course of the study or not using adequate contraception.
  • Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study
  • Any diagnosis or condition that, in the clinician's best judgment, might confound reporting of study outcomes

结局指标

主要结局

Percentage of Low Back Pain Responders

时间窗: 3 months

Percentage of low back pain responders at 3 months post-activation with no increase in opioids from Baseline to 3 months post-activation

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验